Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

NCT ID: NCT03439254

Last Updated: 2023-10-23

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

919 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-30

Study Completion Date

2022-09-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to evaluate whether obeticholic acid (OCA; INT-747) can lead to histological improvement in fibrosis with no worsening of NASH in adults with compensated cirrhosis due to NASH.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Compensated Cirrhosis Nonalcoholic Steatohepatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Obeticholic Acid (OCA) 10 mg

10 mg OCA for up to 18 months

Group Type EXPERIMENTAL

Obeticholic acid (10 mg)

Intervention Type DRUG

Tablets administered orally once daily.

Obeticholic Acid (OCA) 10 mg to 25 mg

10 mg OCA for the first 3 months and then may titrate up to 25 mg OCA for the remaining 15 months of the study

Group Type EXPERIMENTAL

Obeticholic acid (10 mg to 25 mg)

Intervention Type DRUG

Tablets administered orally once daily.

Placebo

Placebo for up to 18 months

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Tablets administered orally once daily.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Obeticholic acid (10 mg)

Tablets administered orally once daily.

Intervention Type DRUG

Obeticholic acid (10 mg to 25 mg)

Tablets administered orally once daily.

Intervention Type DRUG

Placebo

Tablets administered orally once daily.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

OCA 6alpha-ethylchenodeoxycholic acid (6-ECDCA) INT-747 OCA 6alpha-ethylchenodeoxycholic acid (6-ECDCA) INT-747

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1\. Subjects with a confirmed diagnosis of NASH and a fibrosis score of 4 based upon the NASH CRN scoring system determined by central reading

Exclusion Criteria

1. Current or past history of a clinically evident hepatic decompensation event, such as ascites, hepatic encephalopathy (HE), or variceal bleeding
2. Current or past history of CP score ≥7 points
3. Model for End-stage Liver Disease (MELD) score \> 12
4. ALT ≥ 5 X ULN
5. Calculated creatinine clearance \<60mL/min using Cockcroft-Gault method
6. Hemoglobin A1c (HbA1c) ≥ 9.5 %
7. Evidence of other known forms of chronic liver disease such as alcoholic liver disease, hepatitis B, hepatitis C, PBC, PSC, autoimmune hepatitis, Wilson disease, iron overload, alpha-1-antitrypsin deficiency, drug-induced liver injury, known or suspected hepatocellular carcinoma (HCC)
8. History of liver transplant, or current placement on a liver transplant list
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Intercept Pharmaceuticals

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Digestive Health Specialists of the Southeast

Dothan, Alabama, United States

Site Status

Objective GI d/b/a North Alabama GI Research Center

Madison, Alabama, United States

Site Status

Arizona Liver Health

Chandler, Arizona, United States

Site Status

Arizona Liver Health

Glendale, Arizona, United States

Site Status

The Institute for Liver Health

Tucson, Arizona, United States

Site Status

Liver Wellness Center

Little Rock, Arkansas, United States

Site Status

Arkansas Gastroenterology

North Little Rock, Arkansas, United States

Site Status

Hope Clinical Research

Canoga Park, California, United States

Site Status

University of California, San Francisco-Fresno

Fresno, California, United States

Site Status

Scripps Whittier Diabetes Institute

La Jolla, California, United States

Site Status

eStudySite

La Mesa, California, United States

Site Status

Keck Hospital of USC

Los Angeles, California, United States

Site Status

Cedars-Sinani Medical Center

Los Angeles, California, United States

Site Status

Palmtree Clinical Research, INC.

Palm Springs, California, United States

Site Status

Stanford University Medical Center

Palo Alto, California, United States

Site Status

California Liver Research Institute

Pasadena, California, United States

Site Status

Inland Empire Liver Foundation

Rialto, California, United States

Site Status

University of California, Davis Medical Center

Sacramento, California, United States

Site Status

Kaiser Permanente Sacramento Medical Center

Sacramento, California, United States

Site Status

University of California, San Francisco

San Francisco, California, United States

Site Status

University of Colorado Denver and Hospital

Aurora, Colorado, United States

Site Status

Peak Gastroenterology Associates

Colorado Springs, Colorado, United States

Site Status

South Denver Gastroenterology, PC

Englewood, Colorado, United States

Site Status

Innovative Medical Research of South Florida, Inc.

Aventura, Florida, United States

Site Status

Hi Tech and Global Research LLC

Coral Gables, Florida, United States

Site Status

Nature Coast Clinical Research

Inverness, Florida, United States

Site Status

UF Health Jacksonville-Gastroenterology Emerson

Jacksonville, Florida, United States

Site Status

Mayo Clinic Florida

Jacksonville, Florida, United States

Site Status

Schiff Center for Liver Diseases/University of Miami

Miami, Florida, United States

Site Status

Sensible Healthcare, LLC

Ocoee, Florida, United States

Site Status

Innovation Medical Research Center

Palmetto Bay, Florida, United States

Site Status

Gastroenterology Associates of Pensacola, PA

Pensacola, Florida, United States

Site Status

Tampa General Medical Group

Tampa, Florida, United States

Site Status

Guardian Angel Research Center, INC

Tampa, Florida, United States

Site Status

Florida Medical Clinic, P.A

Zephyrhills, Florida, United States

Site Status

Summit Clinical Research, LLC

Athens, Georgia, United States

Site Status

The Emory Clinic (TEC)

Atlanta, Georgia, United States

Site Status

Gastrointestinal Specialists of Georgia

Marietta, Georgia, United States

Site Status

Grand Teton Research Group, PLLC

Idaho Falls, Idaho, United States

Site Status

Rush University Medical Center

Chicago, Illinois, United States

Site Status

Loyola University Medical Center

Maywood, Illinois, United States

Site Status

Aquiant Research

New Albany, Indiana, United States

Site Status

University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status

Kansas Medical Clinic

Topeka, Kansas, United States

Site Status

University of Louisville, Clinical Trials Unit

Louisville, Kentucky, United States

Site Status

Tandem Clinical Research, LLC

Marrero, Louisiana, United States

Site Status

Delta Research Partners, LLC

Monroe, Louisiana, United States

Site Status

Tulane University Health Sciences Center

New Orleans, Louisiana, United States

Site Status

Louisiana Research Center

Shreveport, Louisiana, United States

Site Status

Mercy Medical Center

Baltimore, Maryland, United States

Site Status

Walter Reed National Military Medical Center

Bethesda, Maryland, United States

Site Status

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

Lahey Hospital & Medical Center

Burlington, Massachusetts, United States

Site Status

UMass Memorial Health Care

Worcester, Massachusetts, United States

Site Status

Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center

Wyoming, Michigan, United States

Site Status

Huron Gastroenterology Associates

Ypsilanti, Michigan, United States

Site Status

Minnesota Gastroenterology, P.A.

Saint Paul, Minnesota, United States

Site Status

Southern Therapy and Advanced Research (STAR) LLC

Jackson, Mississippi, United States

Site Status

University of Mississippi Medical Center

Jackson, Mississippi, United States

Site Status

Kansas City Research Institute

Kansas City, Missouri, United States

Site Status

Washington University School of Medicine

St Louis, Missouri, United States

Site Status

CHI Health Alegent Creighton Clinic

Omaha, Nebraska, United States

Site Status

Sierra Clinical Research

Las Vegas, Nevada, United States

Site Status

Amici GI-LLC

Martinsville, New Jersey, United States

Site Status

Rutgers New Jersey Medical School

Newark, New Jersey, United States

Site Status

University at Buffalo, Clinical and Translational Research Center

Buffalo, New York, United States

Site Status

Ichan School of Medicine at Mount Sinai Beth Israel

New York, New York, United States

Site Status

NYU Langone Health

New York, New York, United States

Site Status

Weill Cornell Medical College

New York, New York, United States

Site Status

University of Rochester Medical Center

Rochester, New York, United States

Site Status

Montefiore Medical Center

The Bronx, New York, United States

Site Status

Asheville Gastroenterology Associates, P.A.

Asheville, North Carolina, United States

Site Status

University of North Carolina at Chapel Hill, School of Medicine

Chapel Hill, North Carolina, United States

Site Status

Charlotte Gastroenterology & Hepatology, PLLC

Charlotte, North Carolina, United States

Site Status

Duke University Medical Center

Durham, North Carolina, United States

Site Status

Carolinas Center for Liver Disease/Carolinas HealthCare System

Huntersville, North Carolina, United States

Site Status

Carolinas Health Care System Center for Liver Disease

Huntersville, North Carolina, United States

Site Status

Diabetes & Endocrinology Consultants, PC

Morehead City, North Carolina, United States

Site Status

Trial Management Associates, LLC

Wilmington, North Carolina, United States

Site Status

Dayton Gastroenterology, Inc.

Beavercreek, Ohio, United States

Site Status

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States

Site Status

Northeast Clinical Research Center, LLC

Bethlehem, Pennsylvania, United States

Site Status

The Pennsylvania State University and the Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States

Site Status

Thomas Jefferson University

Philadelphia, Pennsylvania, United States

Site Status

Einstein Healthcare Network

Philadelphia, Pennsylvania, United States

Site Status

UPMC - Center for Liver Diseases at the Thomas E. Starzl Institute

Pittsburgh, Pennsylvania, United States

Site Status

University Gastroenterology

Providence, Rhode Island, United States

Site Status

Ralph H. Johnson Veterans Affairs Medical Center

Charleston, South Carolina, United States

Site Status

SCTR Research Nexus

Charleston, South Carolina, United States

Site Status

Rapid City Medical Center LLP

Rapid City, South Dakota, United States

Site Status

Gastro One

Germantown, Tennessee, United States

Site Status

Associates in Gastroenterology, PLC

Hermitage, Tennessee, United States

Site Status

Johnson City Medical Center

Johnson City, Tennessee, United States

Site Status

Methodist Healthcare University Hospital

Memphis, Tennessee, United States

Site Status

Quaility Medical Research, PLLC

Nashville, Tennessee, United States

Site Status

Vanderbilt University Medical Center - Digestive Disease Center

Nashville, Tennessee, United States

Site Status

Texas Clinical Research Institute LLC

Arlington, Texas, United States

Site Status

The Liver Institute at Methodist Dallas Medical Center

Dallas, Texas, United States

Site Status

Liver Center of Texas

Dallas, Texas, United States

Site Status

Texas Digestive Disease Consultants

Dallas, Texas, United States

Site Status

UT Southwestern Medical Center

Dallas, Texas, United States

Site Status

San Antonio Military Medical Center

Fort Sam Houston, Texas, United States

Site Status

Baylor Scott and White All Saints Medical Center

Fort Worth, Texas, United States

Site Status

Texas Digestive Disease Consultants

Fort Worth, Texas, United States

Site Status

Baylor College of Medicine - Advanced Liver Therapies

Houston, Texas, United States

Site Status

The University of Texas Medical School at Houston

Houston, Texas, United States

Site Status

Centex Studies, Inc.

McAllen, Texas, United States

Site Status

American Research Corporation

San Antonio, Texas, United States

Site Status

Clinical Trials of Texas, Inc.

San Antonio, Texas, United States

Site Status

Texas Digestive Disease Consultants

San Marcos, Texas, United States

Site Status

The University of Vermont Medical Center

Burlington, Vermont, United States

Site Status

Maryview Hospital, Inc. d/b/a Bon Secours Liver Institute of Hampton Roads

Newport News, Virginia, United States

Site Status

Digestive and Liver Disease Specialists

Norfolk, Virginia, United States

Site Status

Bon Secours Richmond Community Hospital, Inc. d/b/a Bon Secours

Richmond, Virginia, United States

Site Status

McGuire VA Medical Center

Richmond, Virginia, United States

Site Status

Virginia Commonwealth University

Richmond, Virginia, United States

Site Status

Gastroenterology Consultants of Southwest Virginia

Roanoke, Virginia, United States

Site Status

Virginia Mason - Seattle Medical Center

Seattle, Washington, United States

Site Status

Harborview Medical Center

Seattle, Washington, United States

Site Status

University of Washington Medical Center

Seattle, Washington, United States

Site Status

Nepean Blue Mountains Local Health District, Nepean Hospital

Kingswood, New South Wales, Australia

Site Status

Mater Misericordiae Limited

South Brisbane, Queensland, Australia

Site Status

Royal Adelaide Hospital

Adelaide, South Australia, Australia

Site Status

Flinders Medical Centre

Bedford Park, South Australia, Australia

Site Status

St Vincent's Hospital

Fitzroy, Victoria, Australia

Site Status

Austin Health

Heidelberg, Victoria, Australia

Site Status

Royal Melbourne Hospital

Parkville, Victoria, Australia

Site Status

University of Calgary Liver Unit (Heritage Medical Research Clinic)

Calgary, Alberta, Canada

Site Status

(G.I.R.I.) GI Research Institute

Vancouver, British Columbia, Canada

Site Status

Queen Elizabeth II Health Sciences Centre, Nova Scotia Health Authority

Halifax, Nova Scotia, Canada

Site Status

Kent Place

Lindsay, Ontario, Canada

Site Status

London Health Sciences Centre-University Hospital

London, Ontario, Canada

Site Status

Office of Dr. Gauthier

North Bay, Ontario, Canada

Site Status

Toronto Liver Centre

Toronto, Ontario, Canada

Site Status

Clinique de medecine Urbaine du Quartier Latin

Montreal, Quebec, Canada

Site Status

Chronic Viral Illness/McGill University Health Centre (MUHC)

Montreal, Quebec, Canada

Site Status

CHU Amiens Picardie

Amiens, , France

Site Status

Centre Hospitalier Universitaire d'Angers

Angers, , France

Site Status

Hôpital Beaujon- Service d'Hepatologie

Clichy, , France

Site Status

Center Hospitalier Universitaire Grenoble Alpes

La Tronche, , France

Site Status

Hôpital de la Croix Rousse

Lyon, , France

Site Status

CHU de Nice, Hôpital de l'Archet 2

Nice, , France

Site Status

Hôpital Pitié-Salpêtrierè

Paris, , France

Site Status

CHU de Rouen-Centre Hospitalier Universitaire

Rouen, , France

Site Status

Centre Hospitalier Universitaire de Strasbourg

Strasbourg, , France

Site Status

Hôpital Hautepierre

Strasbourg, , France

Site Status

Hôpital Purpan

Toulouse, , France

Site Status

CHRU de Nancy - Hôpitaux de Brabois

Vandœuvre-lès-Nancy, , France

Site Status

Hôpital Paul Brousse

Villejuif, , France

Site Status

Univeritätsklinkum Würzburg

Würzburg, Bavaria, Germany

Site Status

Teuber Consulting & Research UG

Frankfurt am Main, Hesse, Germany

Site Status

Universitätsmedizin Mainz

Mainz, Rhineland-Palatinate, Germany

Site Status

EUGASTRO GmbH

Leipzig, Saxony, Germany

Site Status

Universitätsklinikum Leipzig AöR

Leipzig, Saxony, Germany

Site Status

Gastroenterologisch-Hepatologisches Zentrum Kiel

Kiel, Schleswig-Holstein, Germany

Site Status

Charité - Universitätsmedzin Berlin

Berlin, , Germany

Site Status

Universitätsklinikum Hamburg Eppendorf

Hamburg, , Germany

Site Status

Synexus Magyarország Kft. Budapest

Budapest, , Hungary

Site Status

Synexus Magyarorszag Kft. Debrecen A.S.

Debrecen, , Hungary

Site Status

Synexus Magyarorszag Kft. Gyula DRS

Gyula, , Hungary

Site Status

Middlemore Hospital

Auckland, , New Zealand

Site Status

Christchurch Hospital

Christchurch, , New Zealand

Site Status

Dunedin Public Hospital

Dunedin, , New Zealand

Site Status

Wellington Regional Hospital

Wellington, , New Zealand

Site Status

Synexus Polska Sp. z o.o., Oddział w Częstochowie

Częstochowa, , Poland

Site Status

Synexus Polska Sp. z.o.o., Oddział w Gdańsku

Gdansk, , Poland

Site Status

Synexus Polska Sp. Z.o.o., Oddział w Gdyni

Gdynia, , Poland

Site Status

Synexus Polska Sp. z o.o., Oddział w Katowicach

Katowice, , Poland

Site Status

Synexus Polska Sp. z o.o., Oddział w Łodzi

Lodz, , Poland

Site Status

Synexus Polska Sp. z o.o., Oddział w Poznaniu

Poznan, , Poland

Site Status

Synexus Polska Sp. z o.o., Oddział w Warszawie

Warsaw, , Poland

Site Status

Synexus Polska Sp. z o.o., Oddział w Wrocławiu

Wroclaw, , Poland

Site Status

Latin Clinical Trial Center

San Juan, , Puerto Rico

Site Status

Fundación de Investigación de Diego

San Juan, , Puerto Rico

Site Status

Hospital Clínic de Barcelona

Barcelona, , Spain

Site Status

Hospital Universitario La Paz

Madrid, , Spain

Site Status

Hospital Universitario Puerta de Hierro Majadahonda

Madrid, , Spain

Site Status

Hospital Universitario Marqués de Valdecilla

Santander, , Spain

Site Status

Hospital Universitario Virgen del Rocio

Seville, , Spain

Site Status

Hospital General Universitario de Valencia

Valencia, , Spain

Site Status

Hospital Universitari i Politécnic La Fe

Valencia, , Spain

Site Status

Medical Center of LLC Medbud-Clinic, Clinical Diagnostic Department

Kyiv, , Ukraine

Site Status

Kyiv Railway Clinical Hospital №2 of branch "Health Center" of the Joint-Stock Company "Ukranian Railway", Day treatment department

Kyiv, , Ukraine

Site Status

Derby Teaching Hospitals NHS Foundation Trust

Derby, Derbyshire, United Kingdom

Site Status

University Hospitals Birmingham NHS Foundation Trust

Birmingham, England, United Kingdom

Site Status

Royal Free Hospital NHS Foundation Trust

London, England, United Kingdom

Site Status

King's College Hospital NHS Foundation Trust

London, England, United Kingdom

Site Status

Imperial College Healthcare NHS Trust, St Mary's Hospital

London, England, United Kingdom

Site Status

Nottingham University Hospitals NHS Trust

Nottingham, England, United Kingdom

Site Status

Derriford Hospital

Plymouth, England, United Kingdom

Site Status

Oxford University Hospitals NHS Foundation Trust

Oxford, Oxfordshire, United Kingdom

Site Status

The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital

Newcastle upon Tyne, Tyne and Wear, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Canada France Germany Hungary New Zealand Poland Puerto Rico Spain Ukraine United Kingdom

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

747-304

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Norursodeoxycholic Acid vs. Placebo in NASH
NCT05083390 RECRUITING PHASE2